Effect of methylphenidate on physical growth indicators in children and adolescents with attention-deficit/hyperactivity disorder: a systematic review and meta-analysis (opens in new tab)

BackgroundMethylphenidate (MPH) is the first-line medication for attention deficit hyperactivity disorder (ADHD). The results regarding its potential negative impact on the physical growth of children and adolescents with ADHD are inconsistent. Accordingly, the present research aimed to systematically evaluate the influence of MPH monotherapy on physical growth parameters in children and adolescents with ADHD.MethodsA systematic search was conducted across the Cochrane Library, Embase, PubMed...